Drug
Gadodiamide clinical trials
Also written Omniscan.
- studies test it
- 4
- open now
- 1
- in phase 3
- 2
- first study started
- 2003
Keep track of what changes. Save the gadodiamide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
4 studies that test it; most in 2003 (1)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2009 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 2
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Gadolinium ethoxybenzyl DTPA (1) · Gadolinium DTPA (1) · Gadobenic acid (1)
Studies
Open first, then newest update. How each study uses gadodiamide is read from its arms, and is right about nine times in ten.
Testing it · 4
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingPhase 4GuerbetNCT04373564Written as Gadodiamide
- A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using GadodiamideCompletedPhase 3GE HealthcareNCT00209391Written as Gadodiamide Injection
- A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using GadodiamideCompletedPhase 3GE HealthcareNCT00209443Written as Gadodiamide Injection
- Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)CompletedPhase 4GE HealthcareNCT00908310Written as Omniscan
As the comparator · 1 — what is tested is compared with gadodiamide
Codes
What other systems call gadodiamide · ClinicalTrials.gg INT003522
- MeSH (NLM) C064925gadodiamideConfirmed NLM, Wikidata
- UNII (FDA) 84F6U3J2R6GADODIAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 41144Confirmed FDA, Wikidata
- Wikidata Q2031078gadodiamide hydrateConfirmed FDA, NLM, Wikidata
- Wikidata Q72479907GadodiamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65795GadodiamideOne source FDA
- DrugBank DB00225One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C064925 | gadodiamide | Confirmed NLM, Wikidata |
| UNII (FDA) | 84F6U3J2R6 | GADODIAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 41144 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2031078 | gadodiamide hydrate | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q72479907 | Gadodiamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65795 | Gadodiamide | One source FDA |
| DrugBank | DB00225 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.